GERN
Geron Corp
Price:  
1.20 
USD
Volume:  
14,796,492.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-280.9%
Upside

As of 2026-10-02, the Relative Valuation of Geron Corp (GERN) is (2.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.20 USD, the upside of Geron Corp based on Relative Valuation is -280.9%.

The range of the Relative Valuation is (1.88) - (2.62) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.8x - 24.9x 21.4x
Forward P/E multiples 14.7x - 25.0x 19.8x
Fair Price (1.88) - (2.62) (2.17)
Upside -256.3% - -318.7% -280.9%
1.20 USD
Stock Price
(2.17) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2026-09-30 -11.67
2026-09-29 -11.77
2026-09-28 -11.86
2026-09-25 -11.96
2026-09-24 -11.96
2026-09-23 -11.77
2026-09-22 -12.43
2026-09-21 -12.33
2026-09-18 -12.33
2026-09-17 -12.52
2026-09-16 -12.24
2026-09-15 -12.43
2026-09-14 -13.00
2026-09-11 -12.81
2026-09-10 -13.00
2026-09-09 -13.28
2026-09-08 -14.33
2026-09-04 -14.90
2026-09-03 -14.33
2026-09-02 -15.09
2026-09-01 -14.04
2026-08-31 -14.14
2026-08-28 -14.33
2026-08-27 -14.52
2026-08-26 -14.52
2026-08-25 -14.71
2026-08-24 -14.42
2026-08-21 -14.42
2026-08-20 -14.71
2026-08-19 -15.09
2026-08-18 -14.52
2026-08-17 -14.52
2026-08-14 -13.95
2026-08-13 -14.56
2026-08-12 -14.90
2026-08-11 -15.47
2026-08-10 -14.04
2026-08-07 -14.04
2026-08-06 -14.90
2026-08-05 -15.47
2026-08-04 -12.71
2026-08-03 -12.14
2026-07-31 -12.24
2026-07-30 -12.71
2026-07-29 -13.28
2026-07-28 -13.76
2026-07-27 -14.04
2026-07-24 -13.47
2026-07-23 -13.76
2026-07-22 -13.38